BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
Clinical trial NCT04318327 · TERMINATED
Trial details
- NCT number
- NCT04318327
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2025-04-29
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.